Full Length Research Paper
References
Aljitawi O, Shabaneh B, Whitaker J (2005). Bilateral Upper Extremity Thrombophlebitis Related to Intravenous Amiodarone: A Case Report. Southern Med. J. 98(8):813-816. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allam AM, Mostafa W, Zayed E, El-Gamaly J (2007). Management of the acute partial-thickness burned hand; moist exposed burn ointment or silver sulphadiazine cream both combined with a polyethylene bag. Ann. Burn Fire Disaster 20(3):144. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Al-Meshaan M, Abdul HM, Quider T, Al-Sairafi A, Dham R (2008). Role of Mebo (Moist Exposed Burn Ointment) in the Treatment of Fournier'S Gangrene. Ann. burns fire Disaster 21(1):20. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Al-Numairy A (2000). Clinical Use of MEBO in Wounds Management in UAE. Int. J. Cosmet. Surg. Aesthet. Dermatol. 2(1):27-33. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
An Y, Wu MH, Li Y, Peng H, Yang XH (2008). Application of MEBO in Preventing Chemotherapy Phlebitis in 65 Cases. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ang E, Lee ST, Gan CS, Chan YH, Cheung YB, Machin D (2003). Pain control in a randomized, controlled, clinical trial comparing moist exposed burn ointment and conventional methods in patients with partial-thickness burns. J. Burn. Care Rehabil.24:289-296. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ang ES, Lee ST, Gan CS(2002).The role of alternative therapy in the management of partial thickness burns of the face--experience with the use of moist exposed burn ointment (MEBO) compared with silver sulphadiazine. J. Ann. Acad. Med. Singapore. 29(1):7-10. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atiyeh BS, Dham R, Kadry M, Abdallah AF, Al-Oteify M, Fathi O, Samir A (2002). Benefit–cost analysis of moist exposed burn ointment. Burns 28(7):659-663. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Boyce BA, Yee BH (2012). Incidence and Severity of Phlebitis in Patients Receiving Peripherally Infused Amiodarone. Crit. Care Nurs. 32(4):27-34. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chen PF, Shen YS (2008). Application of MEBO MEBO in the Phlebitis Induced by Mannitol. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chen F (2007). Effect of MEBO on preventing and treating phlebitis induced by sodium aescinate. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chen Y (2014). MEBO moisturizing burn cream applied to the clinical evaluation of fat emulsion exudative phlebitis. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Di Nisio M, Peinemann F, Porreca E, Anne WR (2015).Treatment for superficial infusion thrombophlebitis of the upper extremity. Cochrane Database Systematic. Reviews. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
El-Hadidy MR, El-Hadidy AR, Bhaa A, Asker SA, Mazroa SA (2014). Role of epidermal stem cells in repair of partial-thickness burn injury after using Moist Exposed Burn Ointment (MEBO ®) histological and immunohistochemical study. Tissue Cell 46:144-151. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evangelos T,Abdulazeez S (2014). Improving the frequency of visual infusion phlebitis (VIP) scoring on an oncology ward. BMJ Qual. Improv. Rep. 3(1):u2054-w2364. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ezzo J, Berman BM, Vickers AJ, Linde K(1998). Complementary medicine and the Cochrane Collaboration. Jama, 280(18):1628-1630. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Feng X, Zang H (2012). Efficacy of topical application of MEBO in the treatment of phlebitis induced by infusion. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Galgon RE, Strube P, Heier J, Groth J, Wang SJ, Schroeder KM (2015).Magnesium Sulfate with Lidocaine for Preventing Propofol Injection Pain: A Randomized, Double-Blind, Placebo Controlled Trial. J. Anesthesiol. 29(2):206-211. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guan C (2010). Effect of MEBO in treating phlebitis induced by peripheral venous catheterization.Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guan WJ (2006). Treatment of 50 Cases of Chemotherapy Phlebitis with MEBO. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guo G (2016). Preventive effect of MEBO treated with MEBO. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JA (2011). The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 343:d5928. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hindy AMGAD (2009). Comparative study between sodium carboxymethyl-cellulose silver, moist exposed burn ointment, and saline-soaked dressing for treatment of facial burns. Ann. burn Fire Disaster 22(3):131. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hu Y, He XB, Huang H (2012). Efficacy of MEBO in the treatment of drug extravasation after chemotherapy. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Huang A, Kao L, Zeng Y (2008). External application of MEBO in treatment of vinorelbine-induced phlebitis (leakage injury).Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Huang YP, Huang LL, Chen HP (2009). Efficacy of MEBO in treating 50 cases of chemotherapy phlebitis. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jewo PI, Fadeyibi IO ,Babalola OS, Saalu LC, Benebo AS, Izegbu MC, Ashiru OA(2009).A Comparative study of the wound healing |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Johnson JL, He Y, Yalkowsky SH (2003). Prediction of Precipitation-Induced Phlebitis: A Statistical Validation of an In Vitro Model. J. Pharm. Sci. 92(8):1574-1581. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ju HR (2011) Efficacy of MEBO in treating phlebitis induced by amiodarone injection. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kim MH, Young A, Han SH, Kim JH, Hwang JW, Jeon YT (2015). The effect of magnesium sulphate on intubating condition for rapid-sequence intubation: A randomized controlled trial. J. Clin. Anesth. 27:595-601. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kohno E, Murase S, Nishikata M (2008). Research Paper Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits. Int. J. Med. Sci. 5(4)218-223. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leal AD, Kadakia KC, Looker S, Hilger C, Sorgatz K, Anderson K, Jacobson A, Grendahl D, Seisler D, Hobday T, Loprinzi CL (2014). Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapy. Support Care Cancer 22(5):1313-1317. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Li B, Jiang JX, Li CX (2015). Efficacy of MEBO MEBO in treating chemotherapy - induced skin lesions and phlebitis. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Li SD, Zhang XL, Cai XS (2009). Observation of the effect of topical application of MEBO in preventing phlebitis by intravenous. at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Li XZ (2009). Efficacy of External Application of MEBO in Treating Phlebitis. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Li YF, Wang J, Sun JL (2011). Therapeutic effect of MEBO MEBO in treating phlebitis induced by β-aescinate sodium. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lin YZ, Ye L, Ye LL, Chen LL (2013). Therapeutic effect of MEBO MEBO in preventing phlebitis caused by indwelling needle |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liu C ,Yang FL, Zhao XH (2014). Effect of MEBO in treating amiodarone phlebitis. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liu F, Chen D, Liao Y (2012). Apparatus on Phlebitis in a Neurological Intensive Care Unit: A Case-control Study. J. Intern. Med. Res. 40(6)2321-2326. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lu XM (2012). Effect of MEBO in treating phlebitis induced by amiodarone. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Malach T, Jerassy Z, Rudensky B, Schlesinger Y (2006). Prospective surveillance of phlebitis associated with peripheral intravenous catheters. Am. J. Infect. Control 34(5):308-312. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Meng GP, Meng GL (2006). Clinical Application of MEBO in Treating Intravenous Needle Combined with Phlebitis.Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Milutinović D, Simin D, Zec D (2015). Risk factor for phlebitis: A questionnaire study of nurses' perception. Rev. Lat. Am. Enfermagem. 23(4):677-684. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Myrianthefs P, Karatzas S, Baltopoulos G (2005a). Complications, thrombophlebitis rates, and intravenous catheter replacement strategies. Infection 33(2):96-97. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Myrianthefs P, Sifaki M, Samara I, Baltopoulos G (2005b). The epidemiology of peripheral vein complications: Evaluation of the efficiency of differing methods for the maintenance of catheter patency and thrombophlebitis prevention. J. Evaluation Clin. Pract. 11(1):85-89. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ray-Barruel G, Polit DF, Murfield JE, Rickard CM (2014). Infusion phlebitis assessment measures: a systematic review. J. Evaluation Clin. Pract. 20(2):191-202. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ren L (2014). Treatment of infusion phlebitis by MEBO external application: a report of 84 cases. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See GJ, Chan YH, Lee-Hua Ng BN, Machin D (2001). Evaluating the role of alternative therapy in burn wound management: randomized trial comparing moist exposed burn ointment with conventional methods in the management of patients with second-degree burns. Medscape/General Med. 3(12):3-18. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Spiering M (2014).Peripheral Amiodarone-Related Phlebitis: An Institutional Nursing Guideline to Reduce Patient Harm. J. Infusion Nurs. 37(6):453-460. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sun QL, Tian M, Tian BB, Zhang QF, Ding ZG (2016). Efficacy of MEBO in preventing phlebitis induced by surgical indwelling needle. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tagalakis V, Kahn SR, Libman M, Blostein M (2002).The Epidemiology of Peripheral Vein Infusion Thrombophlebitis: A critical review. Am. J. Med. 113(2):146-151. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tang QL, Han SS, Feng J (2014). Moist exposed burn ointment promotes cutaneous excisional wound healing in rats involving VEGF and bFGF. Mol. Med. Rep. 9(4):1277-1282. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thürlimann B, Bachmann I (1992). Effective prevention of chemotherapy-induced phlebitis by low-dose heparin: A prospective randomised trial. Ann. Oncol. 3(4):311-313. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tsati E, Panayotou P, Ioannovich J (2004). Moist exposed burn therapy: evaluation of the wound healing process. An experimental model to assess the efficacy of local agents on wound repair in partial-and full-thickness wounds. European J. Plastic Surg. 27(4):171-177. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vincy LWS (2004) Comparison of Moist Exposed Burn Ointment (MEBO) with Silver Sulfadiazine (Ag-S) for the Treatment of Deep Burn Injury .Hong Kong Baptist University School of Chinese Medicine . Bachelor of Science (Hons) in Biomedical Science April. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Wang Z, Ma LJ, Wang XB (2014).Cimetidine attenuates vinorelbine-induced phlebitis in mice by militating E-selectin expression. Cancer Chemother. Pharmacol. 74:239-247. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xie WR, Lin HY (2014). Nursing Analysis of MEBO MEBO in Treating |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xing YB, Zhang XQ, Chen YF (2012). Application of MEBO in the Infusion Infusion of Intravenous Infusion. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xu J, Bai ZY, Peng X (2013). Efficacy of MEBO MEBO in treating phlebitis. Available at: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yamamoto T, Mori K, Esaki T, Nakao J, Watanabe M (2016). Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral v Y asospasms associated with aneurysmal subarachnoid hemorrhages: A randomized controlled trial . J. Neurosurg.124:18-26. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yan W, Shu-Qian W, Jing Qu (2009). Clinical Experience on Preventing Infant from Phlebitis Caused by the Application of Venous Indwelling Needle with MEBO. Available at:
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0